Four years after grabbing shelved drug, Peninsula company wins FDA approval in prostate cancer
It is the second FDA-approved prostate cancer drug that CEO Lynn Seely has shepherded through clinical trials.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news
More News: American Health | Cancer | Cancer & Oncology | Clinical Trials | Health Management | Prostate Cancer